| Filed On | Filing |
|---|---|
| 21 Apr 2025 |
Form 4: Vakiener Victoria, Director
Disposed of 265,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Sherman Michael A., Director
Returned 423,408 shares to the issuer ($3.62M) · Disposed of 3,974,550 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Riga Thomas J, COO and CCO
Returned 60,828 shares to the issuer ($520K) · Disposed of 1,125,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Multani Pratik S, Director
Disposed of 300,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Middleton Fred A, Director
Returned 3,615,477 shares to the issuer ($30.9M) · Disposed of 324,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Meyer Robert J., Director
Returned 35,150 shares to the issuer ($301K) · Disposed of 324,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Melemed Allen S., CHIEF MEDICAL OFFICER
Returned 173,852 shares to the issuer ($1.49M) · Disposed of 1,428,010 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: LaSpaluto Michelle, CHIEF FINANCIAL OFFICER
Returned 181,541 shares to the issuer ($1.55M) · Disposed of 834,328 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Kozin Marc D, Director
Disposed of 160,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Jakeman David, VP OF FINANCE AND ACCOUNTING
Returned 156,209 shares to the issuer ($1.34M) · Disposed of 311,630 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Demski Martha J, Director
Returned 72,055 shares to the issuer ($616K) · Disposed of 321,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Decker Lisa Lynn, Director
Disposed of 160,000 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Andriole Michael T., Director
Returned 630,828 shares to the issuer ($5.39M) · Disposed of 2,937,825 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 21 Apr 2025 |
Form 4: Alrutz Michael Albert, SVP AND GENERAL COUNSEL
Returned 216,689 shares to the issuer ($1.85M) · Disposed of 1,594,550 Employee Stock Option (Right to Buy) (Disposition to Issuer) |
| 14 Feb 2025 |
Form 4: Melemed Allen S., CHIEF MEDICAL OFFICER
Sold 3,065 shares ($13.8K) |
| 14 Feb 2025 |
Form 4: Andriole Michael T., Director
Sold 7,370 shares ($33.3K) |
| 14 Feb 2025 |
Form 4: Alrutz Michael Albert, SVP AND GENERAL COUNSEL
Sold 1,600 shares ($7.23K) |
| 14 Feb 2025 |
Form 4: Jakeman David, VP OF FINANCE AND ACCOUNTING
Sold 300 shares ($1.36K) |
| 14 Feb 2025 |
Form 4: LaSpaluto Michelle, CHIEF FINANCIAL OFFICER
Sold 2,260 shares ($10.2K) |
| 31 Jan 2025 |
Form 4: Jakeman David, VP OF FINANCE AND ACCOUNTING
Sold 2,800 shares ($11.5K) |
Loading...